From the Department of Emergency Medicine, Alameda Health System, Oakland, CA (ESA, AL, AAH, HA); Substance Use Disorder Treatment Program, Alameda Health System, Oakland, CA (ESA, AAH); University of California San Francisco, School of Medicine, San Francisco, CA (LFW); Howard University College of Medicine, Washington, DC (RB), Lincoln Memorial University, Debusk College of Osteopathic Medicine, Harrogate, TN (KB); Department of Internal Medicine, University of California San Francisco, San Francisco, CA (TD); Andrew Levitt Center for Social Emergency Medicine, Berkeley, CA (HA).
Received for publication September 14, 2021; accepted December 8, 2021.
This study was supported by a grant from the California Healthcare Foundation, Oakland, California.
The authors report no conflicts of interest.
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.journaladdictionmedicine.com).
Send correspondence to Erik S. Anderson, MD, 1411 E 31st Street, Oakland, CA 94602. E-mail: [email protected].